Product correctly added to cart.

discount label
Desacetyl Rifaximin
View 3D

Biosynth logo

Desacetyl Rifaximin

CAS: 80621-88-1

Ref. 3D-FD159579

5mgTo inquire
10mgTo inquire
25mgTo inquire
50mgTo inquire
100mgTo inquire
Estimated delivery in United States, on Wednesday 20 Nov 2024

Product Information

Name:
Desacetyl Rifaximin
Description:

Rifaximin is a pharmaceutical preparation that belongs to the group of rifamycins. It is used for the treatment of inflammatory bowel disease and cancer. Rifaximin has been shown to be effective against inflammatory bowel disease by inhibiting bacterial growth in the intestines. This drug also has an anti-inflammatory effect on polymorphonuclear leukocytes, which are eosinophilic cells involved in the immune response. Rifaximin also inhibits intestinal motility and fluid secretion, which may be due to its ability to inhibit the release of pro-inflammatory cytokines (e.g., IL-8). The use of this drug has been associated with a reduction in polyps and intestinal cancer cells.

Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Biosynth
Long term storage:
Notes:

Chemical properties

Molecular weight:
743.84 g/mol
Formula:
C41H49N3O10
Purity:
Min. 95%
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:

Hazard Info

UN Number:
EQ:
Class:
H Statements:
P Statements:
Forbidden to fly:
Hazard Info:
Packing Group:
LQ:

Technical inquiry about: 3D-FD159579 Desacetyl Rifaximin

Please use instead the cart to request a quotation or an order

If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.

* Mandatory fields.
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.

Please see our Cookies Policy for more details or adjust your preferences in "Settings".